BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32234068)

  • 1. Metastatic malignant melanoma with neuroendocrine differentiation: a case report and review of the literature.
    Juhlin CC; Zedenius J; Haglund F
    J Med Case Rep; 2020 Mar; 14(1):44. PubMed ID: 32234068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous neoplasms composed of melanoma and carcinoma: A rare but important diagnostic pitfall and review of the literature.
    Mejbel HA; Nelson KC; Pradhan D; Ivan D; Zaleski M; Nagarajan P; Tetzlaff MT; Curry JL; Torres-Cabala CA; Prieto VG; Aung PP
    J Cutan Pathol; 2020 Jan; 47(1):36-46. PubMed ID: 31361351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary large cell neuroendocrine carcinoma of the skin: An under-recognized entity and a mimic of metastatic disease.
    Lano IM; Rayson D; Arnason T; Walsh NMG
    J Cutan Pathol; 2018 Jan; 45(1):54-58. PubMed ID: 28960456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant Melanoma With Neuroendocrine Differentiation: A Case Report and Literature Review.
    Cham J; Shavit A; Ebrahimi A; Viray M; Gibbs P; Bhangoo MS
    Front Oncol; 2021; 11():763992. PubMed ID: 34926265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine tumours metastatic to the uvea: diagnosis by fine needle aspiration biopsy.
    Trichopoulos N; Augsburger JJ
    Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):524-8. PubMed ID: 16170536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lymphocytic leukemia and second primary nonlymphoid malignancies: cytopathologic study of 17 cases.
    Fitzthum AD; Wakely PE
    J Am Soc Cytopathol; 2021; 10(3):321-327. PubMed ID: 33168473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
    Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
    Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous metastases of pancreatic neuroendocrine carcinoma.
    Laschinger ME; Naga L; Gaspari AA
    G Ital Dermatol Venereol; 2018 Oct; 153(5):722-724. PubMed ID: 30246953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous endocrine expression and loss of melanoma markers in malignant melanoma metastases, a retrospective analysis.
    Steppert C; Krugmann J; Sterlacci W
    Pathol Oncol Res; 2020 Jul; 26(3):1777-1779. PubMed ID: 31654227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases.
    Eyden B; Pandit D; Banerjee SS
    Histopathology; 2005 Oct; 47(4):402-9. PubMed ID: 16178895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant basomelanocytic tumor manifesting as metastatic melanoma.
    Erickson LA; Myers JL; Mihm MC; Markovic SN; Pittelkow MR
    Am J Surg Pathol; 2004 Oct; 28(10):1393-6. PubMed ID: 15371958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual Neuroendocrine Differentiation in a Small Round Cell Angiosarcoma: A Potential Histologic Mimicker of Superficial Ewing Sarcoma.
    Machado I; Santonja C; Huerta V; Cruz J; Requena C; Requena L; Llombart-Bosch A
    Am J Dermatopathol; 2018 Sep; 40(9):671-675. PubMed ID: 29533277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: Evaluation of 24 cases.
    Leblebici C; Yeni B; Savli TC; Aydın Ö; Güneş P; Cinel L; Şimşek BÇ; Yıldız P; Tuncel D; Kayahan S
    Ann Diagn Pathol; 2019 Jun; 40():53-58. PubMed ID: 31031215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and ultrastructural investigation on cutaneous neuroendocrine carcinoma: report of a case and review of the literature.
    Ishii H; Joshita T; Matsuyama N; Uchida T; Ishikawa A; Ebihara Y
    Med Mol Morphol; 2006 Sep; 39(3):164-8. PubMed ID: 16998628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleural Metastasis From Cutaneous Malignant Melanoma.
    Mytinger AK; Lim KG; Kern RM; Mullon JJ; Edell ES; Saeed AI
    J Bronchology Interv Pulmonol; 2018 Jan; 25(1):54-56. PubMed ID: 28195965
    [No Abstract]   [Full Text] [Related]  

  • 16. Case of low-grade neuroendocrine carcinoma of the skin presenting metastases to lymph nodes and peritoneum.
    Okabayashi A; Nakagawa K; Shimizu N; Tohda-Kinoshita R; Goto K
    J Dermatol; 2019 Aug; 46(8):720-723. PubMed ID: 31206216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual presentation of two simultaneous primary melanomas.
    Wu JJ; Huang DB; Woodruff C; Tyring SK
    Int J Dermatol; 2006 May; 45(5):580-2. PubMed ID: 16700797
    [No Abstract]   [Full Text] [Related]  

  • 18. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Base of tongue metastasis of cutaneous malignant melanoma with rhabdoid and neuroendocrine features: Report of a rare case and review of the literature.
    Tzanavaris K; Pettas E; Thermos G; Georgaki M; Piperi E; Nikitakis NG
    Head Neck Pathol; 2022 Dec; 16(4):1230-1241. PubMed ID: 35524032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant Melanoma With Rhabdomyosarcomatous Differentiation: A Case Report.
    Antonov NK; Niedt GW
    Am J Dermatopathol; 2016 Jun; 38(6):456-60. PubMed ID: 27205908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.